HealthDay - MONDAY, Aug. 4 (HealthDay News) -- Immunotherapy shows promise intreating children with high-risk sarcomas, according to a U.S. NationalInstitute of Health pilot study.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.